Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 7/20 | 0.56 |
| ▸ | PPARG | P37231 | 2/20 | 0.51 |
| ▸ | PPARD | Q03181 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | G6PD | P11413 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taxiphyllin SCHEMBL1332701 | 1.00 | TYR (0.56) | TYRPPARGPPARDPPARAMAPT | |
| Taxiphyllin SCHEMBL467975 | 1.00 | TYR (0.56) | TYRPPARGPPARDPPARAMAPT | |
| Taxiphyllin SCHEMBL12727838 | 1.00 | TYR (0.56) | TYRPPARGPPARDPPARAMAPT | |
| Prunasin SCHEMBL4925774 | 0.88 | SYNJ2 (0.50) | TYRMAPTKDM4EPOLBGAA | |
| Prunasin SCHEMBL30671478 | 0.88 | SYNJ2 (0.50) | TYRMAPTKDM4EPOLBGAA | |
| Prunasin SCHEMBL16147925 | 0.88 | SYNJ2 (0.50) | TYRMAPTKDM4EPOLBGAA | |
| Prunasin SCHEMBL440675 | 0.88 | SYNJ2 (0.50) | TYRMAPTKDM4EPOLBGAA | |
| Prunasin SCHEMBL377612 | 0.88 | SYNJ2 (0.50) | TYRMAPTKDM4EPOLBGAA | |
| SCHEMBL29649717 | 0.88 | TYR (0.60) | TYRPOLB | |
| SCHEMBL30592415 | 0.85 | TYR (0.47) | TYRPPARGPPARDPPARAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 424 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132413-A1 | AROGENATE DEHYDROGENASE POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING THE SAME | WISCONSIN ALUMNI RES FOUNDATION (US) | 2026-05-14 | — | — | US | claimed |
| EP-4649136-A1 | GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF NITROGEN AND CARBON-CONTAINING COMPOUNDS | Fertis India Pvt Ltd (IN) | 2025-11-19 | — | — | EP | claimed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | claimed |
| US-20250136952-A1 | ENGINEERED PREPHENATE DEHYDROGENASES AND AROGENATE DEHYDROGENASES AND METHODS OF USING THE SAME | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2025-05-01 | — | — | US | claimed |
| US-12134788-B2 | Engineered prephenate dehydrogenases and arogenate dehydrogenases and methods of using the same | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2024-11-05 | — | — | US | claimed |
| WO-2024121871-A1 | GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF NITROGEN AND CARBON-CONTAINING COMPOUNDS | FERTIS INDIA PVT. LTD. (IN) | 2024-06-13 | — | — | WO | claimed |
| WO-2024069235-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2024-04-04 | — | — | WO | claimed |
| WO-2022187816-A1 | GENETIC PURITY ESTIMATE METHOD BY SEQUENCING | INDIANA CROP IMPROVEMENT ASSOCIATION (US) | 2022-09-09 | — | — | WO | claimed |
| US-20220282339-A1 | GENETIC PURITY ESTIMATE METHOD BY SEQUENCING | INDIANA CROP IMPROVEMENT ASSOCIATION | 2022-09-08 | — | — | US | claimed |
| US-20210395701-A1 | ENGINEERED PREPHENATE DEHYDROGENASES AND AROGENATE DEHYDROGENASES AND METHODS OF USING THE SAME | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2021-12-23 | — | — | US | claimed |
| CN-103597071-A | Chemosensory receptor ligand-based therapies | ELCELYX THERAPEUTICS INC | 2014-02-19 | — | — | CN | claimed |
| EP-2661266-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | Elcelyx Therapeutics, Inc. (US) | 2013-11-13 | — | — | EP | claimed |
| WO-2012170727-A1 | FLUOROGENIC SEMICONDUCTOR NANOCRYSTALS | Life Technologies Corporation (US) | 2012-12-13 | — | — | WO | claimed |
| WO-2012126059-A1 | NOVEL STOCK FEED CROP PLANT | MONASH UNIVERSITY (AU) | 2012-09-27 | — | — | WO | claimed |
| EP-2486404-A1 | METABOLIC BIOMARKERS OF DRUG-INDUCED CARDIOTOXICITY | Wisconsin Alumni Research Foundation (US) | 2012-08-15 | — | — | EP | claimed |
| WO-2012094636-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | ELCELYX THERAPEUTICS, INC. (US) | 2012-07-12 | — | — | WO | claimed |
| WO-2011044253-A1 | METABOLIC BIOMARKERS OF DRUG-INDUCED CARDIOTOXICITY | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-04-14 | — | — | WO | claimed |
| US-20110081675-A1 | Metabolic Biomarkers Of Drug-Induced Cardiotoxicity | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-04-07 | — | — | US | claimed |
| US-7122657-B2 | UDP-glucose aglycon-glucosytransferase | MOLLER, BIRGER LINDBERG (DK) | 2006-10-17 | — | — | US | claimed |
| US-20050277766-A1 | Udp-glucose aglycon-glucosytransferase | MOLLER, BIRGER LINDBERG (DK) | 2005-12-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132413-A1 | AROGENATE DEHYDROGENASE POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING THE SAME | PNP, RNGTT, DPYD | TYR 527/4885PPARG 2942/4885PPARD 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.